Smith Kevin P. 4

4 · Inogen Inc · Filed Mar 3, 2026

AI-generated summary of this filing

Updated Mar 3, 2026

Inogen (INGN) EVP Kevin P. Smith Receives RSUs, Exercises Derivatives

What Happened

Kevin P. Smith, EVP, Business Development, General Counsel & Secretary of Inogen (INGN), reported multiple equity transactions. On Feb 27, 2026 he was granted 35,000 restricted stock units (RSUs). On Mar 1, 2026 he converted/exercised 14,005 RSUs into common shares; 6,276 of those shares were withheld to satisfy tax withholding (treated as a disposition) at $6.10 per share (withheld value $38,284). Also on Mar 1, 2026 he acquired 1,500 shares through the Company’s 2014 Employee Stock Purchase Plan at $6.10 per share (total $9,150).

Key Details

Transaction dates and prices:
- 2026-02-27: Grant of 35,000 RSUs (derivative award, $0 exercise price).
- 2026-03-01: Conversion/exercise of 14,005 RSUs (reported at $0 for derivative conversion).
- 2026-03-01: 6,276 shares withheld for tax at $6.10 (value $38,284).
- 2026-03-01: ESPP purchase of 1,500 shares at $6.10 (value $9,150).
Shares owned after transaction: Not specified in the provided filing details.
Footnotes of note:
- F1: ESPP purchase under the Company’s 2014 Employee Stock Purchase Plan.
- F2: 6,276 shares were withheld to cover tax withholding on vested RSUs.
- F3: Each RSU represents a contingent right to one share.
- F4/F5: Vesting schedule — 1/3 of the RSUs vested on Mar 1, 2026; 1/3 will vest on Mar 1, 2027 and 1/3 each year thereafter, subject to continued service.
Filing timeliness: Form 4 was filed Mar 3, 2026; no late-filing flag is indicated in the filing provided.

Context

These transactions are largely routine compensation-related activity: a time-based RSU grant and the conversion/vesting of RSUs, with shares withheld to cover taxes (a common cashless mechanism). The ESPP purchase is an employee plan buy, not an open-market investment decision. Derivative/option entries here reflect RSUs converting into shares rather than a cash exercise of an option.

Form 4

Period: 2026-02-27

EVP, Bus Dev, GC & Sec

Transactions

Award
Common Stock
[F1]
2026-03-01$6.10/sh+1,500$9,150→ 14,278 total
Exercise/Conversion
Common Stock
2026-03-01+14,005→ 28,283 total
Tax Payment
Common Stock
[F2]
2026-03-01$6.10/sh−6,276$38,284→ 22,007 total
Award
Restricted Stock Unit
[F3][F4]
2026-02-27+35,000→ 35,000 total
→ Common Stock (35,000 underlying)
Exercise/Conversion
Restricted Stock Unit
[F3][F5]
2026-03-01−14,005→ 28,011 total
→ Common Stock (14,005 underlying)

Footnotes (5)

[F1]Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
[F2]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
[F3]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
[F4]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
[F5]1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

Signature

/s/ Mary Wright, as Attorney-in-Fact|2026-03-03

1 file